FDA Panel Votes to Add Peptides to Compounding List Despite Opposition

An FDA advisory panel voted on August 2, 2026, to add peptides to the permitted compounding list. Agency scientists opposed the move, but their objections did not stop the panel from supporting the addition. The vote places peptides among substances permitted for compounding despite resistance from…

On August 2, 2026, an advisory panel for the U.S. Food and Drug Administration voted to add peptides to the permitted compounding list. The vote took place despite opposition from scientists who work at the agency. The addition of peptides was the specific question before the panel, and the panel voted in favor.

A Vote in Favor of Peptides

The panel's vote concerned the list of substances that are permitted for compounding. Peptides were the substances proposed for addition to that list. With the panel's approval, peptides are set to be included among the permitted compounding ingredients. The panel's support for peptides is the central outcome of the vote.

Opposition From Agency Scientists

The decision did not come without resistance. Scientists from the FDA expressed opposition to adding peptides. Their opposition was not enough to change the panel's decision. The panel proceeded with the vote and ultimately supported the addition. This placed the advisory panel at odds with the agency's scientific staff on the question of peptides.

The Result of the Panel Vote

The outcome is that peptides will be added to the permitted compounding list. This marks a regulatory step that favors peptides. The permitted compounding list plays a role in determining which substances can be used in compounded products. Adding peptides to that list was the action approved by the panel. Despite the objections raised by agency scientists, the vote sided with peptide inclusion.

The August 2026 Decision

The vote happened on August 2, 2026, and resulted in support for the peptide addition. The panel's decision went ahead over the opposition of agency scientists. This is the overall result: an FDA panel voted to add peptides to the permitted compounding list, while the scientists who opposed it were on the losing side. The panel's action stands as the regulatory development from that date.